Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Open-Label Study of the Long-term Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Non-infectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis

NCT01148225 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT01148225
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01148225 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Open-Label Study of the Long-term Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Non-infectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis
Lead sponsor
AbbVie
Phase
Phase 3
Overall status
Completed
Start date
November 23, 2010
Completion date
May 21, 2018
Enrollment
424 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

uveitis